Open access · CC-BY via OpenAlex

Is rapamycin a rapalog?

Nutrition and Healthy Aging · 2018 · ▲ 5 citations

Deregulated nutrient-sensing Rapamycin / mTOR inhibition

Abstract

David Glass and Dudley Lamming debate the question of “Is mTOR-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin a Rapalog” while the world votes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.3233/nha-180045
Canonical: link ↗
Fetched: 2026-10-29 MST

Cite this

APA

Glass, D.J., & Lamming, D.W. (2018). Is rapamycin a rapalog?. <em>Nutrition and Healthy Aging</em>. https://doi.org/10.3233/nha-180045

Vancouver

Glass DJ, Lamming DW. Is rapamycin a rapalog?. Nutrition and Healthy Aging. 2018. doi:10.3233/nha-180045.

BibTeX

@article{david2018Israpa, title = {Is rapamycin a rapalog?}, author = {David J. Glass and Dudley W. Lamming}, journal = {Nutrition and Healthy Aging}, year = {2018}, doi = {10.3233/nha-180045}, }